Immune activation and inflammatory system in chronic heart failure: Novel pathophysiological hypotheses generate new therapeutic options

International Journal of Clinical Practice

Volumn 61, Issue 4, 2007, Pages 536-538

  Piepoli, Massimo F ^a  

^a GUGLIELMO DA SALICETO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PYRIDOSTIGMINE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; BETA ADRENERGIC RECEPTOR BLOCKING; CHEMOSENSITIVITY; CHRONIC INFLAMMATION; CLINICAL PRACTICE; EDITORIAL; EXTRACELLULAR MATRIX; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART RATE VARIABILITY; HUMAN; IMMUNOREACTIVITY; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE; SYSTEMIC CIRCULATION; TREATMENT INDICATION; VAGUS TONE;

AUTONOMIC NERVOUS SYSTEM; HEART FAILURE; HUMANS; INFLAMMATION;

EID: 33947413473     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01313.x     Document Type: Editorial

References (28)

1. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation 1999; 100: 999-1008.
2. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation 2000; 102: 14-23.
3. Francis GS, Rector TS, Cohn JN. Sequential neurohormonal measurements in patients with congestive heart failure. Am Heart J 1988; 116: 1464-8.
4. Ponikowski P, Chua TP, Anker SD et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 2001; 104: 544-9.
5. Francis DP, Willson K, Davies LC, Coats AJ, Piepoli M. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation 2000; 102: 2214-21.
6. Sigurdsson A, Swedberg K. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. Am Heart J 1996; 132: 229-34.
7. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF Study Group). Lancet 1999; 353: 2001-7.
8. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-55.
9. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
10. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 223: 236-41.
11. Torre-Amione G, Kapadia S, Lee J et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-11.
12. Shan K, Kurrelmeyer K, Seta Y et al. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 1997; 12: 218-23.
13. Finkel MS, Oddis CV, Jakob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 157: 387-9.
14. Valgimigli M, Curello S, Ceconi C et al. Neurohormones, cytokines and programmed cell death in heart failure: a new paradigm for the remodeling heart. Cardiovasc Drugs Ther 2001; 15: 529-37.
15. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman ML, Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997; 95: 1247-52.
16. Krown KA, Page MT, Nguyen C et al. Tumor necrosis factor a-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98: 2854-65.
17. Kubota T, McTiernan CF, Frye CS et al. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α. Circ Res 1997; 81: 627-35.
18. Sivasubramanian N, Coker ML, Kurrelmeyer KM et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001; 104: 826-31.
19. Anker SD, Clark AL, Kemp M et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 1997; 30: 997-1001.
20. Torre-Amione G, Kapadia S, Benedict CR, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6.
21. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analyses of cytokine database from the vesnarinone trial (VEST). Circulation 2001; 103: 2055-9.
22. Gong KZ, Song G, Spiers JP, Kelso EJ, Zhang ZG. Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches. Int J Clin Pract 2007; 61: 611-21.
23. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 77: 723-7.
24. Peschel T, Schonauer M, Thiele H, Anker SD, Schuler G, Niebauer J. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail 2003; 5: 609-14.
25. Niebauer J, Volk HD, Kemp M et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353: 1838-42.
26. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J 1998; 19: 761-5..
27. Muller-Werdan U, Werdan K. Immune modulation by catecholamines - a potential mechanism of cytokine release in heart failure? Herz 2000; 25: 271-3.
28. Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD, Poole-Wilson PA. Autonomic imbalance and immune activation in chronic heart failure. Cardiovasc Res 2006; 70: 434-45.